When.com Web Search

  1. Ads

    related to: boston pharmaceutical companies list

Search results

  1. Results From The WOW.Com Content Network
  2. Biotechnology industry in Boston - Wikipedia

    en.wikipedia.org/wiki/Biotechnology_industry_in...

    The biotechnology industry in Boston dates back to the 1970s, when genetic engineering was developing. Biogen was the first company in Boston to focus on biotechnology. [6] [7] In 2008, Massachusetts Governor Deval Patrick announced the Massachusetts Life Sciences Act, promising $1 billion to further the development of the biotech industry.

  3. Category : Health care companies based in Massachusetts

    en.wikipedia.org/wiki/Category:Health_care...

    Boston Scientific (1 C, 2 P) M. Moderna (1 C, 2 P) Pages in category "Health care companies based in Massachusetts" ... Acceleron Pharma; Agios Pharmaceuticals; Alere ...

  4. List of Massachusetts companies - Wikipedia

    en.wikipedia.org/.../List_of_Massachusetts_companies

    This is a list of companies located in Massachusetts ... Boston Beer Company; Boston Scientific; Brine; C ... Millennium Pharmaceuticals; Moderna; N

  5. List of pharmaceutical companies - Wikipedia

    en.wikipedia.org/wiki/List_of_pharmaceutical...

    This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.

  6. Category:Companies based in Boston - Wikipedia

    en.wikipedia.org/wiki/Category:Companies_based...

    Pages in category "Companies based in Boston" The following 200 pages are in this category, out of approximately 306 total. This list may not reflect recent changes .

  7. List of largest pharmaceutical mergers and acquisitions

    en.wikipedia.org/wiki/List_of_largest...

    Valeant Pharmaceuticals: Allergan, Inc: 53.3 69 Valeant raised its unsolicited offer for Allergan a second time, to $53.3 billion, increasing the cash portion of the bid in an effort to win the backing of the company, with the cash-and-stock portion of the bid valuing each Allergan share at $179.25. [26] 16 2014 Valeant Pharmaceuticals ...